Elegen

Elegen is a synthetic biology company founded in 2017 and headquartered in Menlo Park, California that manufactures high-accuracy synthetic DNA through its proprietary cell-free ENFINIA platform. Rather than relying on traditional cell-based cloning, ENFINIA combines microfluidics, artificial intelligence, and robotics to produce long, clonal-quality, high-complexity DNA at speed and low cost. The ENFINIA product line includes Linear DNA up to 7 kb delivered in 6-8 business days, Plasmid DNA up to 15 kb, and IVT Ready DNA with encoded poly(A) tails for mRNA workflows, each NGS-verified to 99.999% per-base accuracy. Elegen serves researchers and therapeutics developers across mRNA vaccines, cell and gene therapy, CRISPR genome editing, and protein expression. Customers submit and order sequences through the online ENFINIA ordering portal; Elegen does not currently publish a public developer API. The company is backed by a16z Bio + Health, KdT Ventures, 8VC, Digitalis Ventures, Agilent, and others, and raised a $35M Series B in 2024.

Elegen is profiled on the APIs.io network. Tagged areas include Company, Synthetic Biology, DNA Synthesis, Biotechnology, and Genomics.

Elegen’s developer surface includes developer portal, documentation, support, engineering blog, pricing, signup flow, and 8 more developer resources.

🌐 Visit website 📡 Source on GitHub

22.5/100 emerging ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanySynthetic BiologyDNA SynthesisBiotechnologyGenomicsGene SynthesisLife SciencesmRNACell and Gene TherapySynthetic DNA

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 22.5/100 · emerging

Contract Quality 0.0 / 25

Developer Ergonomics 4.8 / 20

Commercial Clarity 8.9 / 20

Operational Transparency 0.7 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/elegen: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Get Started 2

Portal, sign-up, and the first successful call

Portal

Portal

SignUp

SignUp

Documentation 1

Reference material describing how the API behaves

Documentation

Documentation

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt

LLMsTxt

Build 1

SDKs, sample code, and the tooling you integrate with

GitHubOrganization

GitHubOrganization

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 3

Pricing, plans, and the legal terms of use

Pricing

Pricing

PrivacyPolicy

PrivacyPolicy

TermsOfService

TermsOfService

Company 4

The organization behind the API

Website

Website

Blog

Blog

LinkedIn

Twitter

Twitter

Source (apis.yml)

aid: elegen
name: Elegen
description: Elegen is a synthetic biology company founded in 2017 and headquartered in Menlo Park, California that manufactures
  high-accuracy synthetic DNA through its proprietary cell-free ENFINIA platform. Rather than relying on traditional cell-based
  cloning, ENFINIA combines microfluidics, artificial intelligence, and robotics to produce long, clonal-quality, high-complexity
  DNA at speed and low cost. The ENFINIA product line includes Linear DNA up to 7 kb delivered in 6-8 business days, Plasmid
  DNA up to 15 kb, and IVT Ready DNA with encoded poly(A) tails for mRNA workflows, each NGS-verified to 99.999% per-base
  accuracy. Elegen serves researchers and therapeutics developers across mRNA vaccines, cell and gene therapy, CRISPR genome
  editing, and protein expression. Customers submit and order sequences through the online ENFINIA ordering portal; Elegen
  does not currently publish a public developer API. The company is backed by a16z Bio + Health, KdT Ventures, 8VC, Digitalis
  Ventures, Agilent, and others, and raised a $35M Series B in 2024.
url: https://raw.githubusercontent.com/api-evangelist/elegen/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- a16z
x-tier: stub
x-tier-reason: portfolio-lead
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://elegenbio.com/wp-content/uploads/2025/08/elegen-mark-200x200-1.png
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Synthetic Biology
- DNA Synthesis
- Biotechnology
- Genomics
- Gene Synthesis
- Life Sciences
- mRNA
- Cell and Gene Therapy
- Synthetic DNA
apis: []
common:
- type: DomainSecurity
  url: security/elegen-domain-security.yml
- type: Website
  url: https://elegenbio.com/
- type: Portal
  name: ENFINIA Ordering Portal
  url: https://ecommerce.elegen.com/
- type: Documentation
  name: Elegen Support & Product Documentation
  url: https://support.elegenbio.com/
- type: Support
  name: Elegen Help Center
  url: https://support.elegenbio.com/
- type: Blog
  name: Elegen News
  url: https://elegenbio.com/news/
- type: GitHubOrganization
  name: ElegenBio on GitHub
  url: https://github.com/ElegenBio
- type: Pricing
  name: ENFINIA GEN II Pricing
  url: https://elegenbio.com/technology/gen-ii-pricing-announcement/
- type: SignUp
  name: ENFINIA Portal Sign Up / Login
  url: https://ecommerce.elegen.com/auth/login
- type: PrivacyPolicy
  url: https://elegenbio.com/privacy-policy/
- type: TermsOfService
  name: Terms and Conditions of Sale
  url: https://support.elegenbio.com/en/kb/terms-and-conditions-of-sale
- type: LinkedIn
  url: https://www.linkedin.com/company/elegenbio/
- type: Twitter
  url: https://x.com/ElegenBio
- type: LLMsTxt
  name: Elegen llms.txt
  url: llms/elegen-llms.txt
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence